内皮祖细胞移植治疗糖尿病足的协同作用因素

背景：糖尿病足治疗已经走到瓶颈,自体骨髓/外周血内皮祖细胞移植是近年来治疗糖尿病足的新方式。目的：针对血管内皮细胞生长因子受体2和整联蛋白在内皮祖细胞移植治疗糖尿病足过程中发挥作用的研究进展进行综述。方法：第一作者应用计算机检索1998年1月至2012年12月PubMed数据库、中国期刊全文数据库有关内皮祖细胞治疗糖尿病足、整合素与血管内皮细胞生长因子受体2的相互作用以及整合素与血管内皮细胞生长因子受体2在内皮祖细胞增殖与血管新生作用方面的文章,英文检索词“diabetic foot,endothelial progenitor cells,VEGFR-2,integrin,synergistic effect”;中文检索词“糖尿病足,内皮祖细胞,血管内皮细胞生长因子受体2,整合素,协同作用”。共检索到98篇相关文献,排除重复研究,60篇文献符合纳入标准。结果与结论：在糖尿病足治疗中,自体骨髓/外周血内皮祖细胞越来越受到重视,并逐渐成为最令人瞩目、最鼓舞人心的焦点,内皮祖细胞移植已经逐渐发展成为糖尿病足治疗的新模式。血管内皮细胞生长因子受体2和整合素在糖尿病足治疗的血管生成中可能发挥了协同作用,但仍有许多机制还不清楚,要彻底明确整合素和血管内皮细胞生长因子的作用机制尚需进一步研究。

Synergistic factors of endothelial progenitor cell transplantation in the treatment of diabetic foot

BACKGROUND:The treatment of diabetic foot has become a “bottleneck”. The transplantation of autologous bone marrow or peripheral blood endothelial progenitor cells is a new way for the treatment of diabetic foot in recent years.OBJECTIVE:To review the effects of vascular endothelial growth factor receptor 2 and the integrin in treatment of diabetes foot by transplantation of endothelial progenitor cells.METHODS:The first author searched PubMed database and Chinese periodical full-text database for related articles published between January 1998 and December 2012, with "diabetic foot, endothelial progenitor cells, VEGFR-2, integrin, synergistic effect" in English and Chinese, respectively. A total of 98 articles were searched, and 60 were included after excluding repetitive articles. RESULTS AND CONCLUSION:In the diabetic foot treatment, autologous bone marrow or peripheral blood endothelial progenitor cells has around increasing attention, and gradually become the focus of this field. Therapy with endothelial progenitor cells has gradually developed into a new method for diabetic foot. Vascular endothelial growth factor receptor 2 and the integrin may exhibit synergistic effects in the treatment of diabetes foot. However, the mechanism remains poorly understood. Further studies are needed to well understand their mechanism of action.